Healthcare ❯Pharmaceuticals ❯Obesity Treatment
Market Trends
Once primarily for diabetes, GLP-1 drugs now account for 5% of U.S. prescriptions, with potential uses ranging from weight loss to treating Alzheimer’s and addiction.
